首頁 > 市場調查報告書 > 醫療設備

市場調查報告書

商品編碼

1629595

護理軟體市場：按產品、按交付形式、按最終用戶、按地區

Long-term Care Software Market, By Product, By Mode of Delivery, By End User, By Geography

出版日期: 2024年11月26日 | 出版商:

Coherent Market Insights | 英文 140 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

2024 年全球護理軟體市場價值估計為 54 億美元，預計 2031 年將達到 90.1 億美元，2024 年至 2031 年的複合年成長率為 7.6%。

報告範圍		報告詳細資訊
基準年	2023	2024 年的市場規模	54億美元
效能資料	2019 年至 2023 年	預測期	2024 年至 2031 年
預測期間 2024 年至 2031 年複合年成長率：	7.60％	2031 年價值預測	90.1億美元

圖。

護理軟體有助於管理老年人住宅設施、成人日托、輔助生活之家和療養院。簡化與居民相關的行政業務，包括藥物管理、計費和服務時間追蹤。全球老齡人口日益增多，容易患慢性疾病和殘疾，這推動了對此類設施的需求。此外，住院醫療費用的上漲也推動了對優質居家照護的需求。這促使護理提供者投資於軟體解決方案，以幫助他們提供優質服務，同時保持生產力並遵守法規。隨著人們對老年護理選擇的認知不斷提高，市場預計將穩步成長。

市場動態：

推動全球老年護理軟體市場發展的關鍵促進因素是導致老年人殘疾的慢性病患病率上升、醫療成本增加促使更多人採用家庭護理解決方案，以及強制在醫療保健中使用數位工具的法規的實施。然而，安裝和維護此類軟體的成本高昂，以及某些地區熟練護理人員的短缺，減緩了其普及速度。機會在於開發更強大的雲端基礎的版本並整合人工智慧功能以遠端監控健康參數。市場開發公司還可以探索人口老化的新興國家的商機。

本研究的主要特點

本報告對全球護理軟體市場進行了詳細分析，並以 2023 年為基準年，給出了預測期（2024-2031 年）的市場規模和年複合成長率（CAGR%）。

它還強調了各個領域的潛在商機並說明了該市場的有吸引力的投資提案矩陣。

它還提供了對市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景以及主要企業採用的競爭策略的重要見解。

它根據公司亮點、產品系列、關鍵亮點、財務業績和策略等參數，對全球老年護理軟體市場的主要企業進行了概述。

主要企業包括雅培 (Abbott)、美敦力 (Medtronic)、Getinge AB、Abiomed、Terumo Corporation、波士頓科學 (Boston Scientific)、羅氏公司 (F. Hoffmann-La Roche Ltd)、拜耳公司 (Bayer AG)、Viatris Inc.、Par Pharmacetical、Xerx 啊和 Chiesi Farmaceutici SpA。

本報告的見解將使負責人和公司經營團隊能夠就未來的產品發布、類型升級、市場擴張和行銷策略做出明智的決策。

本研究報告針對該產業的各個相關人員，包括投資者、供應商、產品製造商、經銷商、新進業者和財務分析師。

相關人員將透過用於分析全球護理軟體市場的各種策略矩陣更輕鬆地做出決策。

Report Coverage	Report Details
Base Year:	2023	Market Size in 2024:	US$ 5.40 Bn
Historical Data for:	2019 To 2023	Forecast Period:	2024 To 2031
Forecast Period 2024 to 2031 CAGR:	7.60%	2031 Value Projection:	US$ 9.01 Bn

Long-term care software helps in the management of senior housing facilities, adult daycare, assisted living, and nursing homes. It streamlines administrative tasks related to residents such as medication management, billing, and tracking service hours. The rising geriatric population globally prone to chronic diseases and disabilities has boosted the need for such facilities. Additionally, the demand for quality care at home has also been on the rise owing to greater medical costs of inpatient care. This has prompted care providers to invest in software solutions that aid in providing quality services while maintaining productivity and regulatory compliance. The market is expected to grow steadily as awareness about senior care options increases.

Market Dynamics:

The key drivers fueling the global long-term care software market include growing prevalence of chronic diseases leading to disabilities among elderly, increasing healthcare costs prompting greater adoption of home-based care solutions, and implementation of regulations mandating use of digital tools in healthcare. However, high installation and maintenance costs of such software as well as lack of skilled nursing staff in some regions are slowing down adoption. The opportunity lies in the development of more robust cloud-based versions and integration of AI capabilities for remotely monitoring health parameters. Market players could also explore opportunities in developing countries witnessing rise in aging population.

Key Features of the Study:

This report provides in-depth analysis of the global long-term care software market, and provides market size (US$ Billion) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players

It profiles key players in the global long-term care software market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies

Key companies covered as a part of this study include Abbott, Medtronic, Getinge AB, Abiomed, Terumo Corporation, Boston Scientific, F. Hoffmann-La Roche Ltd, Bayer AG, Viatris Inc., Par Pharmaceutical, AstraZeneca, Zoll Medical Corporation, Xenios AG (part of Fresenius Medical Care), Windtree Therapeutics, and Chiesi Farmaceutici S.p.A.

Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics

The global long-term care software market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global long-term care software market

Market Segmentation

By Product Insights (Revenue, USD Bn 2019 - 2031)
- Electronic Health Records (EHR)
- Remote Patient Monitoring Systems
- Revenue Cycle Management (RCM)
- Clinical Decision Support Systems
- E-prescribing
- Real-Time Location Systems
- Electronic Medication Administration Record (eMAR)
- E-prescribing
- Billing, Invoicing, and Scheduling Software
- Others
By Mode of Delivery Insights (Revenue, USD Bn, 2019 - 2031)
- Cloud-Based
- Web-Based
- On-Premise
By End User Insights (Revenue, USD Bn, 2019 - 2031)
- Home Healthcare Agencies
- Hospice & Palliative Care
- Nursing Homes
- Assisted Living Facilities
- Others
Regional Insights (Revenue, USD Bn, 2019 - 2031)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
Key Players Insights
- Abbott
- Medtronic
- Getinge AB
- Abiomed
- Terumo Corporation
- Boston Scientific
- Hoffmann-La Roche Ltd
- Bayer AG
- Viatris Inc.
- Par Pharmaceutical
- AstraZeneca
- Zoll Medical Corporation
- Xenios AG (part of Fresenius Medical Care)
- Windtree Therapeutics
- Chiesi Farmaceutici S.p.A.

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Global Long-term Care Software Market, By Product
- Global Long-term Care Software Market, By Mode of Delivery
- Global Long-term Care Software Market, By End User
- Global Long-term Care Software Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Driver
- Restraint
- Opportunity
Impact Analysis
Key Developments
Regulatory Scenario
Product Launches/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario
Industry Trends

4. Global Long-term Care Software Market, By Product, 2019-2031, (USD Bn)

Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Electronic Health Records (EHR)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Remote Patient Monitoring Systems
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Revenue Cycle Management (RCM)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Clinical Decision Support Systems
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
E-prescribing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Real-Time Location Systems
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Electronic Medication Administration Record (eMAR)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
E-prescribing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Billing, Invoicing, and Scheduling Software
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

5. Global Long-term Care Software Market, By Mode of Delivery, 2019-2031, (USD Bn)

Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Cloud-Based
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Web-Based
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
On-Premise
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

6. Global Long-term Care Software Market, By End User, 2019-2031, (USD Bn)

Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Home Healthcare Agencies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Hospice & Palliative Care
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Nursing Homes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Assisted Living Facilities
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

7. Global Long-term Care Software Market, By Region, 2019 - 2031, Value (USD Bn)

Introduction
- Market Share (%) Analysis, 2024, 2027 & 2031, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2020 - 2031, Value (USD Bn)
- Regional Trends
North America
- Introduction
- Market Size and Forecast, By Product, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Mode of Delivery, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By End User, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, By Product, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Mode of Delivery, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By End User, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, By Product, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Mode of Delivery, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By End User, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
  - Germany
  - U.K.
  - Spain
  - France
  - Italy
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, By Product, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Mode of Delivery, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By End User, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, By Product, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Mode of Delivery, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By End User, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
  - GCC Countries
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, By Product, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Mode of Delivery, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By End User, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Country/Region, 2019 - 2031, Value (USD Bn)
  - South Africa
  - North Africa
  - Central Africa

8. Competitive Landscape

Abbott
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Medtronic
Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Getinge AB
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Abiomed
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Terumo Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Boston Scientific
Hoffmann-La Roche Ltd
Bayer AG
Viatris Inc.
Par Pharmaceutical
AstraZeneca
Zoll Medical Corporation
Xenios AG (part of Fresenius Medical Care)
Windtree Therapeutics
Chiesi Farmaceutici S.p.A.